1 paper
Saranya Varakunan, Melissa Stadt, Mohammad Kohandel
Chimeric antigen receptor (CAR) T cell therapy has shown remarkable success in hematological malignancies, yet patient responses remain highly variable and the roles of CD4+ and CD…